|
Study group
|
Plasmodium vivax
|
|---|
| |
n*
|
Expected heterozygosity
|
Polyclonal infections
|
|---|
| | |
Mean±SD
|
%
|
|---|
|
Delivery-periphery
|
21
|
0.876 ± 0.072
|
47
|
|
Delivery-placenta
|
23
|
0.869 ± 0.093
|
33
|
|
Antenatal
|
31
|
0.847 ± 0.073
|
84
|
|
Non-pregnant
|
42
|
0.874 ± 0.046
|
73
|
|
p
| |
0.3373
|
0.0004
|
| |
Plasmodium falciparum
|
|
Delivery-periphery
|
20
|
0.554 ± 0.120
|
5
|
|
Delivery-placenta
|
22
|
0.629 ± 0.145
|
8
|
|
Antenatal
|
20
|
0.481 ± 0.103
|
25
|
|
Non-pregnant
|
41
|
0.353 ± 0.215
|
25
|
|
p
| |
<0.0001
|
0.1462
|
- *Number of samples successfully amplified for at least one molecular marker in each species.
